Investigation reveals ultrarapid lispro reduces hypoglycemia in adults with type 1 diabetes during exercise.
Using Lyumjev in conventional CSII pump therapy provides more effective BRRs prior to exercise compared with Humalog, with fewer hypoglycemic events in active adults with type 1 diabetes.
No takes yet. Share an insight, caveat, or question.
Leohr et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: